Literature DB >> 27638003

NAS agar is more suitable than McKay agar for primary culture of Streptococcus milleri group (SMG) fastidious bacteria, S. intermedius in particular.

Vladislav Raclavsky1,2, Radko Novotny3, Lubomir Stary4, Lucie Navratilova3,5, Jaromir Zatloukal6, Petr Jakubec6, Martin Zapalka7, Frantisek Kopriva7, Vitezslav Kolek6.   

Abstract

Streptococcus milleri group (SMG) is a group of three streptococcal species (S. anginosus, intermedius and constellatus) that act as opportunist pathogens, among others in cystic fibrosis. Due to their fastidious character, they are both difficult to cultivate and to differentiate from less pathogenic streptococcal species, therefore being most probably underdiagnosed. Semi-selective McKay agar and NAS agar were developed to facilitate SMG recovery from clinical samples; however, direct comparison of recovery rates has not been published yet. We tested the performance of both media on 123 patient samples and demonstrated general superiority of NAS agar for SMG recovery during primary cultivation convincingly. This observation was also confirmed by quantitative drop tests during subculture. Despite the undisputed overall superiority of NAS agar over McKay agar, a smaller fraction of strains grew better on McKay agar. Inter-strain differences were the most probable explanation. Therefore, when economic conditions are not limiting and maximum recovery rate is desirable, both plates are advised to be used in parallel for primary cultivation of clinical samples.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27638003     DOI: 10.1007/s12223-016-0470-y

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  6 in total

1.  Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.

Authors:  M Miravitlles; C Espinosa; E Fernández-Laso; J A Martos; J A Maldonado; M Gallego
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

2.  A simple, semiselective medium for anaerobic isolation of anginosus group streptococci from patients with chronic lung disease.

Authors:  Richard D Waite; David W Wareham; Samuel Gardiner; Robert A Whiley
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

3.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

Review 4.  The Streptococcus milleri group--an unrecognized cause of disease in cystic fibrosis: a case series and literature review.

Authors:  Michael D Parkins; Christopher D Sibley; Michael G Surette; Harvey R Rabin
Journal:  Pediatr Pulmonol       Date:  2008-05

5.  The Streptococcus milleri group in chronic obstructive pulmonary disease.

Authors:  Lucie Navratilova; Jan Bardon; Radko Novotny; Jaromir Zatloukal; Petr Jakubec; Vitezslav Kolek; Martin Zapalka; Frantisek Kopriva; Petra Prochazkova; Vladislav Raclavsky
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2016-04-21       Impact factor: 1.245

6.  McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients.

Authors:  Christopher D Sibley; Margot E Grinwis; Tyler R Field; Michael D Parkins; Jens C Norgaard; Daniel B Gregson; Harvey R Rabin; Michael G Surette
Journal:  J Med Microbiol       Date:  2010-01-21       Impact factor: 2.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.